“You can’t drive the car while looking in the rearview mirror,” AstraZeneca PLC VP of Business Development Operations Shaun Grady said during an interview at the Biotechnology Industry Organization convention in San Diego, explaining that the company has put the “Pfizer episode” behind it. The British pharma fended off a takeover gambit from Pfizer Inc. just a month ago, but the situation has all eyes on AstraZeneca’s next steps ([A#14140526001]).
“It’s been an extraordinary experience. The thing that’s really striking is how focused everyone has been,” said Grady. “Rather than...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?